Owlet, Inc.OWLTEarnings & Financial Report
Owlet, Inc. is a pediatric health technology firm that develops smart wearable monitoring products for infants, most notably its signature smart sock that tracks real-time heart rate, oxygen levels, and sleep metrics. It serves global consumer markets across North America, Europe, and Asia-Pacific, distributing products via direct-to-consumer e-commerce and partnered retail outlets, focused on supporting parental peace of mind and infant health safety.
Revenue
$22.1M
Gross Profit
$11.5M
Operating Profit
$-4.8M
Net Profit
$-5.6M
Gross Margin
52.2%
Operating Margin
-21.8%
Net Margin
-25.4%
YoY Growth
140.9%
EPS
$-0.61
Owlet, Inc. Q3 FY2024 Financial Summary
Owlet, Inc. reported revenue of $22.1M (up 140.9% YoY) for Q3 FY2024, with a net profit of $-5.6M (up 0.5% YoY) (-25.4% margin). Cost of goods sold was $10.6M, operating expenses totaled $16.4M.
Key Financial Metrics
| Total Revenue | $22.1M |
|---|---|
| Net Profit | $-5.6M |
| Gross Margin | 52.2% |
| Operating Margin | -21.8% |
| Report Period | Q3 FY2024 |
Owlet, Inc. Annual Revenue by Year
Owlet, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $105.7M).
| Year | Annual Revenue |
|---|---|
| 2025 | $105.7M |
| 2024 | $78.1M |
| 2023 | $54.0M |
| 2022 | $69.2M |
Owlet, Inc. Quarterly Revenue & Net Profit History
Owlet, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $26.6M | +29.6% | $-9.2M | -34.6% |
| Q3 FY2025 | $32.0M | +44.6% | $4.1M | 12.9% |
| Q2 FY2025 | $26.1M | +25.9% | $-37.6M | -144.4% |
| Q1 FY2025 | $21.1M | +43.1% | $3.0M | 14.3% |
| Q4 FY2024 | $20.5M | -2.5% | $-9.1M | -44.2% |
| Q3 FY2024 | $22.1M | +140.9% | $-5.6M | -25.4% |
| Q2 FY2024 | $20.7M | +58.2% | $-1.1M | -5.5% |
| Q1 FY2024 | $14.8M | +37.4% | $3.3M | 22.2% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.8M | $20.7M | $22.1M | $20.5M | $21.1M | $26.1M | $32.0M | $26.6M |
| YoY Growth | 37.4% | 58.2% | 140.9% | -2.5% | 43.1% | 25.9% | 44.6% | 29.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $43.8M | $45.9M | $56.1M | $49.5M | $51.4M | $63.5M | $74.9M | $85.6M |
| Liabilities | $65.6M | $66.7M | $65.5M | $66.3M | $63.4M | $108.0M | $113.5M | $50.2M |
| Equity | $-32.9M | $-33.4M | $-21.5M | $-29.8M | $-25.8M | $-59.2M | $-54.1M | $19.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.4M | $-3.4M | $-7.5M | $3.0M | $-5.9M | $-2.2M | $-2.2M | $-452000 |